IBDEI0KS ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10186,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10186,1,4,0)
 ;;=4^204.02
 ;;^UTILITY(U,$J,358.3,10186,1,5,0)
 ;;=5^ALL,In Relapse
 ;;^UTILITY(U,$J,358.3,10186,2)
 ;;=^336465
 ;;^UTILITY(U,$J,358.3,10187,0)
 ;;=204.12^^67^672^17
 ;;^UTILITY(U,$J,358.3,10187,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10187,1,4,0)
 ;;=4^204.12
 ;;^UTILITY(U,$J,358.3,10187,1,5,0)
 ;;=5^CLL,In Relapse
 ;;^UTILITY(U,$J,358.3,10187,2)
 ;;=^336466
 ;;^UTILITY(U,$J,358.3,10188,0)
 ;;=204.20^^67^672^114
 ;;^UTILITY(U,$J,358.3,10188,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10188,1,4,0)
 ;;=4^204.20
 ;;^UTILITY(U,$J,358.3,10188,1,5,0)
 ;;=5^Subacute LL w/o Remission
 ;;^UTILITY(U,$J,358.3,10188,2)
 ;;=^336852
 ;;^UTILITY(U,$J,358.3,10189,0)
 ;;=204.21^^67^672^116
 ;;^UTILITY(U,$J,358.3,10189,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10189,1,4,0)
 ;;=4^204.21
 ;;^UTILITY(U,$J,358.3,10189,1,5,0)
 ;;=5^Subacute LL,In Remission
 ;;^UTILITY(U,$J,358.3,10189,2)
 ;;=^267526
 ;;^UTILITY(U,$J,358.3,10190,0)
 ;;=204.22^^67^672^115
 ;;^UTILITY(U,$J,358.3,10190,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10190,1,4,0)
 ;;=4^204.22
 ;;^UTILITY(U,$J,358.3,10190,1,5,0)
 ;;=5^Subacute LL,In Relapse
 ;;^UTILITY(U,$J,358.3,10190,2)
 ;;=^336467
 ;;^UTILITY(U,$J,358.3,10191,0)
 ;;=205.02^^67^672^5
 ;;^UTILITY(U,$J,358.3,10191,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10191,1,4,0)
 ;;=4^205.02
 ;;^UTILITY(U,$J,358.3,10191,1,5,0)
 ;;=5^AML,In Relapse
 ;;^UTILITY(U,$J,358.3,10191,2)
 ;;=^336470
 ;;^UTILITY(U,$J,358.3,10192,0)
 ;;=205.12^^67^672^20
 ;;^UTILITY(U,$J,358.3,10192,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10192,1,4,0)
 ;;=4^205.12
 ;;^UTILITY(U,$J,358.3,10192,1,5,0)
 ;;=5^CML,In Relapse
 ;;^UTILITY(U,$J,358.3,10192,2)
 ;;=^336471
 ;;^UTILITY(U,$J,358.3,10193,0)
 ;;=284.81^^67^672^14
 ;;^UTILITY(U,$J,358.3,10193,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10193,1,4,0)
 ;;=4^284.81
 ;;^UTILITY(U,$J,358.3,10193,1,5,0)
 ;;=5^Aplastic Anemia d/t Drugs
 ;;^UTILITY(U,$J,358.3,10193,2)
 ;;=^335245
 ;;^UTILITY(U,$J,358.3,10194,0)
 ;;=284.89^^67^672^13
 ;;^UTILITY(U,$J,358.3,10194,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10194,1,4,0)
 ;;=4^284.89
 ;;^UTILITY(U,$J,358.3,10194,1,5,0)
 ;;=5^Aplastic Anemia d/t Chronic Disease
 ;;^UTILITY(U,$J,358.3,10194,2)
 ;;=^87880
 ;;^UTILITY(U,$J,358.3,10195,0)
 ;;=289.84^^67^672^119
 ;;^UTILITY(U,$J,358.3,10195,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10195,1,4,0)
 ;;=4^289.84
 ;;^UTILITY(U,$J,358.3,10195,1,5,0)
 ;;=5^Thrombocytopenia,Heparin Induced
 ;;^UTILITY(U,$J,358.3,10195,2)
 ;;=^336542
 ;;^UTILITY(U,$J,358.3,10196,0)
 ;;=V10.91^^67^672^67
 ;;^UTILITY(U,$J,358.3,10196,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10196,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,10196,1,5,0)
 ;;=5^H/O Neuroendocrine CA Tumor
 ;;^UTILITY(U,$J,358.3,10196,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,10197,0)
 ;;=V10.91^^67^672^66
 ;;^UTILITY(U,$J,358.3,10197,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10197,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,10197,1,5,0)
 ;;=5^H/O Malignant Neoplasm,Unspec
 ;;^UTILITY(U,$J,358.3,10197,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,10198,0)
 ;;=465.9^^67^673^70
 ;;^UTILITY(U,$J,358.3,10198,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10198,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,10198,1,5,0)
 ;;=5^URI
 ;;^UTILITY(U,$J,358.3,10198,2)
 ;;=URI^269878
 ;;^UTILITY(U,$J,358.3,10199,0)
 ;;=462.^^67^673^61
 ;;^UTILITY(U,$J,358.3,10199,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,10199,1,4,0)
 ;;=4^462.
 ;;^UTILITY(U,$J,358.3,10199,1,5,0)
 ;;=5^Sore Throat
